title: Treatment of vulval Crohn's disease with infliximab.
abstract: Anti-tumour necrosis factor-alpha therapy of Crohn's disease (CD) with infliximab has proved a major advance in the treatment of patients with difficult disease. We report our experience of the use of infliximab in a patient with recalcitrant vulval CD. The introduction of infliximab has improved disease control, although a search for an optimum remittive dosing schedule is ongoing.
authors: Department of Dermatology, Worcestershire Royal Hospital, Worcester, UK. pwpreston@doctors.org.uk
authors: P W
authors: PW
authors: Preston
authors: N
authors: N
authors: Hudson
authors: F M
authors: FM
authors: Lewis